Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
Leukemia Drug Shows Promise in Dementia With Lewy Bodies
The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with Lewy bodies (DLB), a small phase II trial